A retrospective observational study assessing the impact of adherence to inhaled corticosteroid/long-acting beta-Agonists (Fluticasone propionate/salmeterol) in patients with asthma
Latest Information Update: 06 Sep 2023
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 27 Jun 2021 New trial record
- 19 May 2021 Results presented at the 117th International Conference of the American Thoracic Society